ZA738976B - Occlusion compound of a silver alkanolamine complex and cycloheptaamylose - Google Patents

Occlusion compound of a silver alkanolamine complex and cycloheptaamylose

Info

Publication number
ZA738976B
ZA738976B ZA738976A ZA738976A ZA738976B ZA 738976 B ZA738976 B ZA 738976B ZA 738976 A ZA738976 A ZA 738976A ZA 738976 A ZA738976 A ZA 738976A ZA 738976 B ZA738976 B ZA 738976B
Authority
ZA
South Africa
Prior art keywords
cycloheptaamylose
alkanolamine complex
occlusion compound
silver alkanolamine
silver
Prior art date
Application number
ZA738976A
Other languages
English (en)
Inventor
A Hadhanyi
Original Assignee
Trommsdorff H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trommsdorff H filed Critical Trommsdorff H
Publication of ZA738976B publication Critical patent/ZA738976B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA738976A 1972-12-11 1973-11-26 Occlusion compound of a silver alkanolamine complex and cycloheptaamylose ZA738976B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2260536A DE2260536C3 (de) 1972-12-11 1972-12-11 MolekiileinschluBverbindungen aus einem Silberalkanolammin-Komplex und beta-Cycloheptaamylose, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ZA738976B true ZA738976B (en) 1974-11-27

Family

ID=5864075

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA738976A ZA738976B (en) 1972-12-11 1973-11-26 Occlusion compound of a silver alkanolamine complex and cycloheptaamylose

Country Status (14)

Country Link
US (1) US3911115A (de)
JP (1) JPS49133512A (de)
AT (1) AT317250B (de)
BE (1) BE808464A (de)
CA (1) CA1010854A (de)
CH (1) CH590880A5 (de)
DE (1) DE2260536C3 (de)
ES (1) ES421313A1 (de)
GB (1) GB1433828A (de)
HU (1) HU166786B (de)
NL (1) NL7316976A (de)
SE (1) SE409461B (de)
SU (1) SU520906A3 (de)
ZA (1) ZA738976B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU180183B (en) * 1980-12-19 1983-02-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing stable suppository compositions containing volatile and/or labile active substances
IL76889A0 (en) * 1984-11-02 1986-02-28 Johnson Matthey Plc Solubilised platinum compound,method for the production thereof and pharmaceutical compositions containing the same
BE1004467A3 (nl) * 1990-06-18 1992-11-24 Sollie Philippe Stikstof- en zilverhoudend derivaat.
TW224049B (de) * 1991-12-31 1994-05-21 Sunkyong Ind Ltd
AU5153399A (en) 1998-08-14 2000-03-06 Coloplast A/S Stabilised compositions having antibacterial activity
US6027469A (en) * 1998-12-03 2000-02-22 Johnson; Lee D. Disinfecting system for hemodialysis apparatus
ATE282957T1 (de) * 2000-09-29 2004-12-15 Coloplast As Stabilisierte zusammensetzungen mit antibakterieller wirkung
US20030185889A1 (en) * 2002-03-27 2003-10-02 Jixiong Yan Colloidal nanosilver solution and method for making the same
US20040180093A1 (en) * 2003-03-12 2004-09-16 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
US7285576B2 (en) 2003-03-12 2007-10-23 3M Innovative Properties Co. Absorbent polymer compositions, medical articles, and methods
US20050123590A1 (en) * 2003-12-05 2005-06-09 3M Innovative Properties Company Wound dressings and methods
US7745509B2 (en) 2003-12-05 2010-06-29 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
US20050123621A1 (en) * 2003-12-05 2005-06-09 3M Innovative Properties Company Silver coatings and methods of manufacture
US8399027B2 (en) 2005-04-14 2013-03-19 3M Innovative Properties Company Silver coatings and methods of manufacture
US20070166399A1 (en) 2006-01-13 2007-07-19 3M Innovative Properties Company Silver-containing antimicrobial articles and methods of manufacture
US20100098949A1 (en) * 2006-10-18 2010-04-22 Burton Scott A Antimicrobial articles and method of manufacture
US8734876B2 (en) * 2009-12-29 2014-05-27 David A. French Confectionary product and method of manufacture and use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2923704A (en) * 1957-05-15 1960-02-02 Hoffmann La Roche Cycloamylose sulfates and derivatives thereof
US3122534A (en) * 1958-02-04 1964-02-25 Avebe Coop Verkoop Prod Amylose derivatives

Also Published As

Publication number Publication date
AU6307373A (en) 1975-06-05
BE808464A (fr) 1974-03-29
SE409461B (sv) 1979-08-20
GB1433828A (en) 1976-04-28
SU520906A3 (ru) 1976-07-05
AT317250B (de) 1974-08-26
DE2260536B2 (de) 1974-12-05
CH590880A5 (de) 1977-08-31
CA1010854A (en) 1977-05-24
HU166786B (de) 1975-05-28
DE2260536A1 (de) 1974-07-04
NL7316976A (de) 1974-06-13
ES421313A1 (es) 1976-04-16
US3911115A (en) 1975-10-07
DE2260536C3 (de) 1975-07-10
JPS49133512A (de) 1974-12-21

Similar Documents

Publication Publication Date Title
ZA738976B (en) Occlusion compound of a silver alkanolamine complex and cycloheptaamylose
IL42900A0 (en) A net and its manufacture
CS380473A2 (en) Insekticidni prostredek a zpusob vyroby ucinnych latek
ZA733013B (en) New benzo-diazepin derivatives and a process for their manufacture
AU475106B2 (en) A clasp for a bracelet
MY7900030A (en) A gate and store circuit
CA970944A (en) Stitch-bonded fabric including a method of and a device for manufacturing same
CA994597A (en) Method of encasing a product
ZA734769B (en) A 15-substituted-w-pentanorprosta-glandins
CA993379A (en) Package and method of making a package
CA986796A (fr) Collecteur a naissain
IE38437L (en) Benzimidazoles; fungicides and bactericides
IL39273A0 (en) A solution comprising a lacrymator
IL41868A0 (en) Pharmaceutical preparations containing d-penicillamine
IT980022B (it) Magnetofono a nastro
IL42600A0 (en) New bis-piperazino-androstane derivatives and a process for the preparation thereof
GB1359800A (en) Method of manufacturing a hectrographic original
IL42099A0 (en) A silencer
CA993603A (en) Precious metal sensitizing solutions
GB1403746A (en) Preparation of transition metal complexes
CA894798A (en) Adamantyl thiosemicarbazone
AU5199273A (en) Azlactones
CA914185A (en) Orotamides and salts thereof
CA904274A (en) Adamantyl urea derivatives
CA917377A (en) Rigid connection between a plastic and metal body